| A case of argyria after colloidal silver ingestion. | |
| | |
MedLine Citation:
|
PMID: 17177941 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Argyria is often considered an entity of the past, one which has largely disappeared with the cessation of silver usage in oral medications. However, with the practice of colloidal silver ingestion in current "alternative health" treatments, argyria should be considered in the differential diagnosis of blue-gray hyperpigmentation. METHODS: A single case report with clinicopathological correlation. RESULTS: Histological examination of skin biopsy specimen, which showed perieccrine brown-black granules, verified that colloidal silver rather than a prescribed medication was the source of the patient's dyspigmentation. |
| | |
Authors:
|
Anne Lynn S Chang; Vista Khosravi; Barbara Egbert |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of cutaneous pathology Volume: 33 ISSN: 0303-6987 ISO Abbreviation: J. Cutan. Pathol. Publication Date: 2006 Dec |
Date Detail:
|
Created Date: 2006-12-20 Completed Date: 2007-02-09 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 0425124 Medline TA: J Cutan Pathol Country: Denmark |
Other Details:
|
Languages: eng Pagination: 809-11 Citation Subset: IM |
Affiliation:
|
Department of Dermatology, Stanford University Medical Center, Stanford, CA 94305, USA. alschang@stanford.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Anti-Ulcer Agents / therapeutic use Antidepressive Agents, Tricyclic / therapeutic use Antilipemic Agents / therapeutic use Antipsychotic Agents / therapeutic use Argyria / complications, pathology* Cholestyramine Resin / therapeutic use Colloids Complementary Therapies Diabetes Mellitus / drug therapy Diagnosis, Differential Gastroesophageal Reflux / complications, drug therapy Humans Hyperlipidemias / complications, drug therapy Hyperpigmentation / pathology Hypertension / complications, drug therapy Hypertrophy / complications Hypoglycemic Agents / therapeutic use Male Middle Aged Prostate / pathology Silver Compounds / toxicity* Skin / pathology* Stress Disorders, Post-Traumatic / complications, drug therapy |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Ulcer Agents; 0/Antidepressive Agents, Tricyclic; 0/Antilipemic Agents; 0/Antipsychotic Agents; 0/Colloids; 0/Hypoglycemic Agents; 0/Silver Compounds; 11041-12-6/Cholestyramine Resin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Analysis of the expression pattern of glial cell line-derived neurotrophic factor, neurturin, their ...
Next Document: Endocrine mucin-producing sweat gland carcinoma: report of a case and review of the literature.